HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ling Han Selected Research

4-vinyl-2,6-dimethoxyphenol

2/2019Dietary canolol induces apoptosis in human cervical carcinoma HeLa cells through ROS-MAPK mediated mitochondrial signaling pathway: In vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ling Han Research Topics

Disease

37Psoriasis (Pustulosis Palmaris et Plantaris)
01/2022 - 10/2008
27Neoplasms (Cancer)
01/2022 - 06/2006
20Inflammation (Inflammations)
11/2021 - 01/2005
14Infections
01/2022 - 04/2008
10Fibrosis (Cirrhosis)
08/2022 - 08/2013
6Death (Near-Death Experience)
01/2022 - 01/2017
6Cognitive Dysfunction
10/2021 - 09/2003
5Psoriatic Arthritis
01/2022 - 12/2015
5Hypertension (High Blood Pressure)
01/2022 - 12/2008
5Uterine Cervical Neoplasms (Cancer of the Cervix)
04/2019 - 02/2011
5Congenital Heart Defects (Congenital Heart Defect)
10/2013 - 11/2004
4Hepatocellular Carcinoma (Hepatoma)
01/2022 - 02/2014
4Chronic Renal Insufficiency
01/2022 - 08/2013
4Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 02/2018
4Arthritis (Polyarthritis)
01/2022 - 08/2015
4Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 09/2008
4Non-alcoholic Fatty Liver Disease
01/2022 - 01/2018
4Necrosis
01/2021 - 01/2005
4Lymphoma (Lymphomas)
09/2014 - 06/2009
4Acute Kidney Injury (Acute Renal Failure)
10/2013 - 04/2013
3Chronic Kidney Failure (Chronic Renal Failure)
01/2022 - 08/2013
3Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 01/2018
3Lung Neoplasms (Lung Cancer)
01/2022 - 11/2014
3Mitochondrial Diseases (Mitochondrial Disease)
01/2022 - 10/2020
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2021
3Tuberous Sclerosis (Bourneville's Disease)
10/2021 - 12/2017
3Breast Neoplasms (Breast Cancer)
09/2021 - 01/2020
3Dementia (Dementias)
01/2021 - 06/2003
3Autoimmune Diseases (Autoimmune Disease)
01/2021 - 01/2018
3Wounds and Injuries (Trauma)
10/2020 - 04/2014
3Nasopharyngeal Carcinoma
07/2020 - 07/2010
3Heart Failure
05/2020 - 01/2016
3Myocardial Infarction
07/2019 - 11/2005
3Carcinoma (Carcinomatosis)
02/2019 - 01/2016
3Skin Diseases (Skin Disease)
12/2018 - 07/2016
3Hyperplasia
03/2017 - 08/2015
3Myocardial Ischemia (Ischemic Heart Diseases)
01/2016 - 02/2002
3Ischemia
01/2015 - 02/2002
3Pneumonia (Pneumonitis)
11/2014 - 01/2005
3Urinary Bladder Neoplasms (Bladder Cancer)
07/2011 - 08/2010
2Pulmonary Fibrosis (Fibrosing Alveolitis)
03/2022 - 11/2014
2Endometriosis
01/2022 - 01/2016
2Pain (Aches)
01/2022 - 01/2021
2Rhabdomyoma
10/2021 - 04/2018
2Chronic Pain
01/2021 - 01/2017
2Alzheimer Disease (Alzheimer's Disease)
01/2021 - 01/2021
2Infertility (Sterility)
01/2021 - 02/2016

Drug/Important Bio-Agent (IBA)

18Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2004
14Imiquimod (Aldara)FDA LinkGeneric
01/2021 - 07/2016
13Messenger RNA (mRNA)IBA
10/2020 - 07/2004
11Biomarkers (Surrogate Marker)IBA
01/2021 - 10/2012
10MicroRNAs (MicroRNA)IBA
11/2021 - 12/2012
9CytokinesIBA
01/2021 - 03/2014
7Pharmaceutical PreparationsIBA
01/2021 - 10/2004
7Therapeutic UsesIBA
01/2021 - 07/2016
6Polysaccharides (Glycans)IBA
01/2022 - 01/2011
6Interleukin-6 (Interleukin 6)IBA
01/2021 - 04/2015
5Peptides (Polypeptides)IBA
08/2022 - 01/2005
5Methotrexate (Mexate)FDA LinkGeneric
01/2022 - 01/2019
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 01/2005
5Interleukin-17 (Interleukin 17)IBA
01/2021 - 10/2018
4CollagenIBA
08/2022 - 01/2018
4selonsertibIBA
01/2022 - 01/2018
4Immunosuppressive Agents (Immunosuppressants)IBA
01/2020 - 01/2018
4ChemokinesIBA
04/2019 - 06/2010
3Long Noncoding RNAIBA
01/2022 - 02/2018
3Glycoproteins (Glycoprotein)IBA
01/2022 - 01/2014
3LipidsIBA
01/2022 - 08/2019
3Interleukin-23 (Interleukin 23)IBA
01/2021 - 11/2014
3AntioxidantsIBA
01/2021 - 07/2017
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 08/2013
3EnzymesIBA
10/2020 - 01/2005
3CreatinineIBA
01/2019 - 09/2013
3Biological ProductsIBA
03/2018 - 08/2010
3Blood Group Antigens (Blood Groups)IBA
01/2018 - 03/2013
3Antidepressive Agents (Antidepressants)IBA
01/2012 - 09/2008
2NLR ProteinsIBA
08/2022 - 03/2021
2EpitopesIBA
01/2022 - 01/2017
2UromodulinIBA
01/2022 - 02/2016
2Cytochromes c (Cytochrome c)IBA
01/2022 - 01/2022
2simtuzumabIBA
01/2022 - 01/2018
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2022 - 03/2007
2Caspase 3 (Caspase-3)IBA
01/2022 - 01/2022
2GraphiteIBA
12/2021 - 11/2021
2SolutionsIBA
12/2021 - 11/2021
2trans-sodium crocetinate (crocetin)IBA
10/2021 - 04/2018
2Opioid Analgesics (Opioids)IBA
01/2021 - 01/2017

Therapy/Procedure

25Therapeutics
01/2022 - 11/2004
8Activities of Daily Living (ADL)
10/2021 - 06/2003
5Drug Therapy (Chemotherapy)
09/2021 - 12/2011
4Home Nursing (Nursing, Home)
01/2021 - 01/2005
4Length of Stay
01/2021 - 06/2003
4Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2021 - 01/2019
3Immunotherapy
01/2021 - 12/2011
3Radiotherapy
01/2021 - 07/2010
3Artificial Respiration (Mechanical Ventilation)
01/2021 - 07/2013
3Cardiopulmonary Bypass (Heart-Lung Bypass)
10/2013 - 04/2013
2Photochemotherapy (Photodynamic Therapy)
01/2022 - 01/2021
2Terminal Care (Care, Terminal)
01/2022 - 01/2021
2Polypharmacy
01/2021 - 01/2018